---
title: "GRAY MARY ANN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/a4282fc0-2f5f-522e-bfb6-aeeb79ebd0b6
json: https://whiteintel.dev/api/public/dossier/a4282fc0-2f5f-522e-bfb6-aeeb79ebd0b6
identifier: sec:0001261974
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GRAY MARY ANN

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001261974`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/a4282fc0-2f5f-522e-bfb6-aeeb79ebd0b6  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/a4282fc0-2f5f-522e-bfb6-aeeb79ebd0b6  

## Ownership & control

### Holdings / subsidiaries

- **Compass Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/993db6cf-f6f6-5d9c-937e-5f1c59a8f44a
- **Keros Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/a1f3a750-7449-5fdf-8e6b-180e9aada175
- **Compass Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/993db6cf-f6f6-5d9c-937e-5f1c59a8f44a
- **RAPT Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/4f0433a4-5bee-5850-8bbd-9658cd44fdf7
- **BioAtla, Inc.** (director) — https://whiteintel.dev/entity/69ba3574-3f47-5885-a70e-02c41cf69c83
- **PALISADE BIO, INC.** (director) — https://whiteintel.dev/entity/515fb831-95af-59df-a366-37e32a781084
- **Sarepta Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/e5124c31-cdb6-50b8-9569-bb5ec4c8c48d
- **SENOMYX INC** (director) — https://whiteintel.dev/entity/e2847232-4327-5e05-b108-f994dc1bfedb
- **COLUMBIA LABORATORIES INC** (director) — https://whiteintel.dev/entity/1013c19a-423e-54f2-aa16-09535d68515d
- **SELLAS Life Sciences Group, Inc.** (director) — https://whiteintel.dev/entity/a0c28abc-fcde-583e-a7c2-ad64e18d0126
- **ACADIA PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/e0daead6-1fdc-534a-ae81-4152b4e37d9f
- **DYAX CORP** (director) — https://whiteintel.dev/entity/3310e76e-3ab2-54ec-8e26-bada8483a24e
- **DYAX CORP** (other) — https://whiteintel.dev/entity/3310e76e-3ab2-54ec-8e26-bada8483a24e
- **TETRALOGIC PHARMACEUTICALS CORP** (director) — https://whiteintel.dev/entity/fc2f3f04-019f-538e-8c18-6c4c9e1c4caf
- **GENZYME TRANSGENICS CORP** (director) — https://whiteintel.dev/entity/e78a1b1b-e889-56b8-ac66-649dfa64098d
- **MABVAX THERAPEUTICS HOLDINGS, INC.** (director) — https://whiteintel.dev/entity/e645c7c1-8720-5927-8f9c-f4d3b4602f96

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GRAY MARY ANN**. Human view: https://whiteintel.dev/entity/a4282fc0-2f5f-522e-bfb6-aeeb79ebd0b6 · Structured JSON: https://whiteintel.dev/api/public/dossier/a4282fc0-2f5f-522e-bfb6-aeeb79ebd0b6._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._